Yang Fan1, Xiaocheng Wei1, Long Qian1, Jing Wang2, and Bing Wu1
1GE Healthcare China, Beijing, China, 2Center for Medical Device Evaluation, NMPA, Beijing, China
Synopsis
4D
flow MRI shows great potential in neurovascular disorders such as stenosis,
atherosclerotic disease, aneurysms, and vascular malformations. Its
widespread application in neurovascular system requires evidence of good
test-retest multi-center reproducibility. The purpose of this study is to
assess the multi-center reproducibility and test-retest reliability of 4D flow
MRI in measurements of cerebral blood flow/velocity in main intracranial
vessels. As a result, high multi-center reproducibility and test-retest
reliability was shown for 4D flow MRI in the measurements of blood flow and peak
velocity of main intracranial vessels for healthy volunteers.
Introduction
4D
flow MRI shows great potential in neurovascular disorders such as stenosis,
atherosclerotic disease, aneurysms, and vascular malformations1,2.
Its widespread application in neurovascular system requires evidence of good
test-retest multi-center reproducibility 3. The purpose of this
study is to assess the multi-center reproducibility and test-retest reliability
of 4D flow MRI in measurements of cerebral blood flow/velocity in main
intracranial vessels. Methods
With
the approval of the local ethics board, ten healthy subjects (4 females, age
from 22 to 33 years) were included in this study. To assess the multi-center
reproducibility and test-retest reliability, all subjects underwent 4D flow MRI
scans at three different centers and scanned twice on two different days at
each center.
All experiments were conducted on GE Discovery
MR750 scanners with a standard 8 channel head coil. 4D flow acquisition was
performed using the method described in ref (4). A k-t acceleration method,
kat-ARC, with a variable density random (VDR) sampling scheme was used leading
to an overall under-sampling factor of 8. All 4D flow scans were acquired with
the same parameters as following: TE/TR = 2.6 ms/5.1 ms, flip angle = 8o,
FOV = 220 x 220 mm2, matrix size = 192 x 192, velocity encoding sensitivity
along all three directions = 80 cm/s. A total of 92 sagittal slices were
acquired to cover the whole brain with a slice thickness = 2 mm, and was then interpolated
to 1 mm using zero filling interpolation. The total scan time was about 6~10
mins depending on the heart rate.
4D flow data analysis was performed using the Arterys software (Arterys
Inc, San Francisco, CA). For each scan, region of interest (ROI) based
measurements of blood flow (L/min) and peak velocity (cm/s) were performed in five
ROIs, bilateral C1 segment of internal carotid arteries (ICAs), bilateral M1
segment of medial cerebral arteries (MCAs) and the superior sagittal sinus.
Shapiro-Walk test was conducted to assess
normality of measurements in each scan. Coefficient of variances (CV) was
computed to evaluate intra- and inter-site variances of all measurements. The
multi-center reproducibility was assessed by two-way mixed intra-class
correlation coefficient (ICC). Bland-Altman plot and Pearson correlation were
used to evaluate test-retest reliability.Results
For
illustration, processed 4D flow images of one typical volunteer at two time
points from two centers are shown in Fig. 1. Similar vessel morphology and
blood velocity field from test and retest scans from different centers were
observed. Besides, the blood flow waveforms of left ICA and left MCA of the
same subject are also demonstrated in Fig. 1. CVs of both intra- and
inter-sites scans are summarized in Fig. 2. Both intra- and inter-site CVs were
lower than 12%. Comparing with the CVs of intra-site measurements, inter-sites
CVs tend to have higher values for both blood flow and peak velocity. Besides,
the CVs of bilateral MCA seem to have increased values compared to those of
bilateral ICA.
To test the normality of data for further
analysis, a series of Shapiro-Walk tests were performed. All p-values for Shapiro-Walk test were
greater than 0.05, which indicated the normality of all measurements. Assessment
of multi-center reproducibility was performed using ICC (see Table 1). Great
multi-center reproducibility was observed for blood flow measurements (all ICC
values were larger than 0.9). For peak velocity measurements, all ICC values
were greater than 0.8, except that of left MCA (ICC = 0.77). Therefore, good
multi-center reproducibility of peak velocity measurements was obtained. The
Bland-Altman plot was used to assess test-retest reliability of the blood flow
and peak velocity. The Bland-Altman plots and correlation analysis for blood
flow and peak velocity are depicted in Fig. 3 and Fig 4, respectively. Both
blood flow and peak velocity showed good test-retest agreements in all measured
cerebral vessels (mean difference < 5%). Correlation analysis also showed
significant test-retest agreement (all r
> 0.75 and p < 0.001). Discussion and Conclusion
High multi-center reproducibility and test-retest
reliability was shown for 4D flow in the measurements of blood flow and peak
velocity of main intracranial vessels for healthy volunteers. Although further studies
need to be done in patients, it may facilitate the potential applications of 4D
flow MRI in neurovascular system. Acknowledgements
No acknowledgement found.References
[1] Schnell
S, Wu C, Ansari SA. 4D MRI flow examinations in cerebral and extracerebral
vessels. Ready for clinical routine? Current opinion in neurology
2016;29(4):419.
[2] Turski
P, Scarano A, Hartman E, et al. Neurovascular 4DFlow MRI (Phase Contrast MRA):
emerging clinical applications. Neurovascular Imaging 2016;2(1).
[3] Schrauben
EM, Johnson K, Huston J, et al. Reproducibility of cerebrospinal venous blood
flow and vessel anatomy with the use of phase contrast–vastly undersampled
isotropic projection reconstruction and contrast-enhanced MRA. American Journal
of Neuroradiology 2014;35(5):999-1006.
[4] Lai
P, Shimakawa A, Cheng JY, Alley MT, Vasanawala S, Brau AC. Sub-8-minute cardiac
four dimensional flow MRI using kat ARC and variable density signal averaging.
Journal of Cardiovascular Magnetic Resonance 2015;17(Supplement 1):Q36.